(Reuters) -Otsuka’s drug for a type of kidney disease showed over 50% reduction in protein in patient’s urine in a late-stage trial, the Japan-based company said on Friday.
(Reporting by Sriparna Roy in Bengaluru)
(Reuters) -Otsuka’s drug for a type of kidney disease showed over 50% reduction in protein in patient’s urine in a late-stage trial, the Japan-based company said on Friday.
(Reporting by Sriparna Roy in Bengaluru)

Comments